Optimal Detection of Atrial Fibrillation in TIA

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 516 participants.

Also called NCT04075500

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 516 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04075500
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04075500. Randomized; single masking; primary purpose diagnostic. Start 2019-03-12 (actual); primary completion 2024-03-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Optimal Detection of Atrial Fibrillation in TIA
Acronym
ODEA-TIA
Intervention (Device)
Subcutaneously implanted event recorder (REVEAL LINQ)
Intervention (Device)
28-day non-invasive continuous ECG (electrocardiogram) monitoring (patch)
Lead sponsor
Alfried Krupp Krankenhaus (class: other)
Collaborator
Medtronic Bakken Research (class: industry)
Collaborator
Coordinating Centre for Clinical Trials Heidelberg (class: not stated)
Collaborator
Wuerzburg University Hospital (class: other)

Record details

Record id
cardio:ct-nct04075500
Content hash
81790c30b0b1e2b42cc95ffebc59123294dc5ee02496022832a91dd54e666112